| Recommendation |
| 50. There is insufficient evidence to issue a recommendation on the use of tocilizumab in critically ill adults with COVID-19. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.